The oligopeptidase B serine protease is an important virulence factor and therapeutic target in Trypanosoma infections. Recently, the Leishmania major Genome Project identified a new oligopeptidase B that was denominated oligopeptidase B-like, herein named oligopeptidase B-2. In this study, a complete open reading frame of oligopeptidase B-2 from Leishmania amazonensis (PH8 strain) was amplified by PCR using primers designed for the oligopeptidase B-2 gene of L. major. The 2,715 bp fragment coded for a protein of 905 amino acids with a predicted molecular mass of 103,918.9 Da and theoretical pI of 5.82. The encoded protein displayed ~96% identity with L. major and ~75% identity with Trypanosoma cruzi and T. brucei oligopeptidases B-2, and ~21% identity with Escherichia coli and L. amazonensis classical oligopeptidase B. An unusual C-terminal extension was found in relation to the classical trypanosomatid oligopeptidase B. By sequence alignment, we determined a catalytic triad (Ser 629, Asp 717 and His 758), S1 subsite (Glu 674 and Glu 676) and suggest a difference in the S2 subsite of L. amazonensis oligopeptidase B-2. We also found that the oligopeptidase B-2 gene is expressed in all cycle stages of L. amazonensis. A phylogenetic analysis indicated that oligopeptidase B-2 is a new member of oligopeptidase B.
Introduction
The leishmaniases are parasitic diseases with a wide range of clinical symptoms that affect over 12 million people in 88 countries. At least 17 species of the protozoan parasites of the genus Leishmania may cause the lethal visceral leishmaniasis or cutaneous leishmaniasis and its disfiguring diffuse and mucocutaneous forms. The diseases are transmitted by sandflies, which inoculate the promastigote forms of the parasite into the skin during bloodmeal and these will in turn infect local and incoming macrophages (Chappuis et al. 2007) .
The number of cases of visceral and cutaneous leishmaniasis is increasing worldwide including in Brazil (Shaw 2007) . Recently, it was observed that Leishmania amazonensis is increasing its geographical distribution in Brazil by clinical presentations in new transmission areas (Azeredo-Coutinho et al. 2007 ) and in new hosts such as dogs (Tolezano et al. 2007) . L. amazonensis is the main agent of the anergic diffuse cutaneous leishmaniasis that frequently fail to respond to antimony therapy. These findings demonstrate a great public health problem because this species can also cause mucocutaneous visceral and post kala azar dermal leishmaniasis (Barral et al. 1991) . Since the available pentavalent antimonials, amphotericin B, pentamidine, paromomycin and miltefosine have proved inadequate in many instances (Vermelho et al. 2007 , Mishra et al. 2007 , the development of novel, more effective and less toxic antileishmanial drugs is an urgent priority.
The search of new drug targets is a rational strategy in the development of new antiparasitic agents. Protozoan proteases have been considered as pre-eminent target groups in several pathologies, and the importance of Leishmania proteases has been confirmed by the finding that specific protease inhibitors kill parasites and reduce the evolution of leishmanial lesions (Sadij and McKerrow 2002) . Trypanosoma sp. oligopeptidase B is emerging as an important virulence factor, and as a disease mechanism (Burleigh and Woolsey 2002) . A major signaling pathway that regulates cell invasion by Trypanosoma cruzi involves mobilization of Ca +2 from intracellular stores and requires the activity of oligopeptidase B (Burleigh and Woolsey 2002) . Furthermore, enzymes from African trypanosomes are active in the bloodstream of infected hosts, and oligopeptidase B from Trypanosoma evansi in-activated atrial natriuretic factor in the bloodstream of the infected host (Morty et al. 2005) .
To date, no oligopeptidase B enzymes have been identified in or cloned from mammalian cells. The fact that this serine protease is not present in humans makes it an ideal molecular target for the development of new chemotherapeutic approaches against Trypanosomatidae. Oligopeptidase B is a therapeutic target in trypanosomal infections (Cazzulo 2002) . In sleeping sickness, the first-line drug pentamidine has been shown to reduce the activity of these oligopeptidases in Trypanosoma brucei (Morty et al. 1998) indicating the importance of this enzyme for parasite survival. Since pentamidine is also used for treating leishmaniasis (Mishra et al. 2007) , it is feasible that oligopeptidase B also serves as a critical Leishmania target.
In the Leishmania major genome, peptidases represent 2% of protein-coding genes in the Tritryps; however, no trypsin/chymotrypsin family serine peptidases were found (Ivens et al. 2005) . Two oligopetidases B have been identified in the L. major genome. The first one was demonstrated by Morty (1999) and then annotated by the genome project (Ivens et al. 2005) , confirming the presence of this enzyme previously characterized in other trypanosomatids. The other oligopeptidase B was denominated oligopeptidase B-like. However, since the genome publication, this oligopeptidase B-like has not been characterized yet. This very oligopeptidase B-like is referred to in this work as oligopeptidase B-2.
In this study, primers designed from the L. major oligopeptidase B-2 gene were used to clone a complete coding sequence of oligopeptidase B-2 from L. amazonensis. Comparison of the deduced amino acid sequences of oligopeptidase B-2 from L. amazonensis demonstrate that oligopeptidases B-2 from different trypanosomatids are closely related in terms of sequence identity and demonstrate differences compared to classical oligopeptidases B.
Materials and methods

Parasites
Leishmania amazonensis (IFLA/BR/67/PH8) and Leishmania major (MRHO/SU/59/P) promastigote forms were maintained at 26°C in M199 with 10% (v/v) heat-inactivated fetalcalf serum. Procyclic stage was obtained after 1-2 days in culture. Metacyclic stage was obtained after 5-6 days in culture by Ficoll density gradient (Spath and Beverley 2001) . Axenic amastigotes from L. amazonensis was obtained by in vitro promastigote-amastigote differentiation (Alves et al. 2005) . Cell numbers were estimated by counting the parasites in a Neubauer chamber.
PCR assay, cloning and sequencing
Genomic DNA was extracted from 1 × 10 8 mixed procyclic and metacyclic promastigotes of L. major and L. amazonensis, according to Sambrook and Russel (2001) . DNA quantification was performed in a Gene Quant pro RNA/DNA calculator. The PCR reaction was performed with 100 ng of extracted DNA using OLIB-2_F1 (atggctgcactttttccgtgggtg) and OLIB-2_R1 (tacggcttcccgcgttgctcctcttg) primer set designed based on the nucleotide sequence of oligopeptidase B-2 from L. major. The PCR was amplified in a 25 µl of reaction volume containing 1U of Platinum Taq (Invitrogen), 1× Platinum Taq buffer, 1.5 mM MgCl 2 , 200 µM of deoxynucleosides triphosphates, 5% of DMSO and 20 pMol of each primer. The amplification program was carried out as follows: 95°C for 5 min, 35 repeated cycles of 1 min at 95°C, 1 min at 64°C and 2 min at 72°C, followed by a single terminal extension at 72°C for 15 min. All reactions were performed in an Eppendorf Matercycler. The PCR products were electrophoresed in 1% agarose (Sigma). A single band spanning the entire L. amazonensis open reading frames (ORFs) was purified and cloned in the pGem T cloning vector. The plasmids were automatically sequenced using specific primers -OLIB2_F1, OLIB2_R1, OLIB2_F2 (atcgtgagcatcgagtttggctcc) and OLIB2_R2 (cccgcgcatgttcatcgctgccgc) and primers from the vector -M13_F (cgccagggttttcccagtcacgac) and M13_R (tcacacaggaaacagcattgac).
Sequence analysis
Sequences of oligopeptidases B and oligopeptidases B-2 were extracted from swiss-prot/TrEMBL. Molecular mass and pI were determined by the protParam program (Gasteiger et al. 2005) . Sequence alignments were carried out with proteinprotein basic local alignment search tool BLAST 2 sequences using default parameters (Altschul et al. 1997) , with ClustalW using default parameters (Higgins et al. 1994) , T-Coffee using default parameters (Notredame et al. 2000) and LALIGN program (Huang and Miller 1991) . All programs are located at www.expasy.org.
Construction of phylogenetic tree
To study the phylogenetic relationship of oligopeptidase B-2 in the prolyl oligopeptidase family, we identified homologous sequences using the BLAST algorithm (http://www.ncbi.nlm. nih.gov/blast). Alignment of the identified sequences was performed using the T-Coffee program (Notredame et al. 2000) . Construction of phylogenetics tree used the MEGA program version 3.1 (Kumar et al. 2004 ). We used a final alignment of 42 taxa with 256 sites based on sequences of catalytic domain (N539-L778 of oligopeptidase B-2). We used neighbor-joining methods to construct phylogenetics. All bootstrap support values are based on 500 replicates.
Detection of products expressed from the L. amazonensis oligopeptidase B gene
Total RNA was extracted from approximately 1 × 10 8 parasites cells in the procyclic phase, metacyclic phase and axenic amastigotes by homogenization in 1 ml of Trizol reagent (Invitrogen). DNA contamination was eliminated by treatment with Dnase I (Boehringer Mannheim, Germany). RNA was quantitated using a spectrophotometer and 5 µg of RNA was used to synthesize cDNA with the SuperScript Indirect 198 OEl¹ski Oligopeptidase B-2 from L. amazonensis with an unusual C-terminal extension cDNA Labeling Kit (Invitrogen). The expression level of oligopeptidase B-2 was estimated by PCR using specific primers (OLIB-2_F1 and OLIB-2_R1). Primers designed for the ITS region were used as controls (Dávila 2002) .
Results and discussion
Cloning, sequencing, and analysis of the oligopeptidase B-2 The oligopeptidase B-2 gene of L. amazonenis was obtained by PCR using primers based on the sequence of L. major (Fig.  1A) . The single band was detected in the PCR using genomic DNA of L. amazonensis and L. major (used as a control for the PCR reaction). The oligopeptidase B-2 gene isolated from L. amazonensis consisted of an ORF of 2,715 base pairs, encoding a polypeptide of 905 amino acids ( Fig. 1) with a predicted molecular mass of 103,918.9 Da, and a predicted pI value of 5.82. This sequence was submitted to GenBank with the accession number EF392368.
Sequence alignment analysis
The encoded oligopeptidase B-2 from Leishmania shared 96% identity with L. major and L. infantum, 93.3% with L. braziliensis and ~75% with T. cruzi and T. brucei oligopeptidase B-2 (Table I ). The identity observed between oligopeptidases B-2 of Leishmania spp. and Trypanosoma spp. (75%) is less than observed between oligopeptidases B-2 of T. cruzi and T. brucei (82%). Interestingly, oligopeptidases B-2 is more conserved than classical trypanosomatid oligopeptidases B (Guedes et al. 2007) . Sequence alignments with oligopeptidases B-2 from other trypanosomatids indicated conservation of the entire sequence with an absence of gaps (not shown).
Therefore, sequence alignments of oligopeptidases B-2 from trypanosomatids with classical trypanosomatid oligopeppeptidases B and bacterial oligopeptidases indicated that major conservation appears to be located in the catalytic domain (Table I ). The encoded oligopeptidase B-2 from L. amazonensis shared ~21% identity with bacterial oligopeptidase B (Table I) , while oligopeptidase B from L. amazonensis shared 36% identity (Guedes et al. 2007) .
Mapping of the catalytic domain, subsites and oxanion
The preference of oligopeptidase B for cleavage after paired basic residues is intriguing since these sites are abundant in precursors of biologically active molecules and are recognized as sites for processing and are based on S1 and S2 subsite recognition (Morty et al. 2002) . The catalytic triad and S1 subsite are present at the same position of the Prolyl oligopeptidase and oligopetidase B (Gerczei et al. 2000) . Using alignment of bacterial oligopeptidases with trypanosomatid oligopeptidases B-2, we determined a catalytic triad and subsite S1 from L. amazonensis (Fig. 2) . We observed conservation in the catalytic triad (Ser 629, Asp 717 and His 758) and S1 subsite (Glu 674 and Glu 676) (Fig. 2) . The conservation of S1 subsite confirms that this new protein is an oligopeptidase B. The maintenance of the S1 subsite, which is responsible for primary specificity, suggests that oligopeptidase B-2 displays cleavage after basic residues. However, we observed a modification at the S2 position. A pair of residues, Asp 460 and Asp 462, was defined for bacterial oligopeptidase B that may be involved in defining P2 specificity (Morty et al. 2002 , Gerczei et al. 2000 . Trypanosome oligopeptidases B demonstrate great similarity, since they have two glutamic acids at the same position (Morty et al. 1999) . However, in oligopeptidases B-2 from trypanosomatids, serine and histidine were observed at the same position. The substitution of aspatic acid or glutamic acid for serine and histidine at the S2 position demonstrates different biochemical characteristics. These modifications suggest different substrate specificities based at the P2 position or that other residues may be involved in preferential cleavage by oligopeptidase B-2 after the pair of basic residues.
In addition, we observed an insertion before His 758 and a deletion after this same amino acid of catalytic triad, indicating modification in the catalytic domain organization. Trypanosomatid oligopeptidases B-2 display Tyr-549 and Ala- (Fig. 2) . In trypanosomatid oligopeptidases B, Tyr and Ala were observed at the same positions, indicating the conservation of an oxanion position in oligopeptidases B and oligopeptidases B-2.
The unusual C-terminal extension
Several insertions and deletions were observed in trypanosomatid oligopeptidase B-2 in relation to classical bacterial and trypanosomatid oligopeptidases B. The major difference was that oligopeptidases B-2 display a N-terminal extension at position 1 to 40 (result not shown) in relation of bacterial oligopeptidases B and a C-terminal extension at position 791-905 that is absent in bacterial oligopeptidases B and in classical oligopeptidase B of trypanosomatid (Fig. 2) . The additional C-terminal extension domain has been observed in several parasite proteins, for example in Schistosoma spp. and in Trypanosomatidae. In Schistosoma spp. this unusual C-terminal extension was observed in aspartic protease with 43 amino acids (Becker et al. 1995 , Wong et al. 1997 . No function has been assigned yet for this domain, but it does not seem to be necessary for enzyme activity. In Trypanosomatidae, the unusual additional C-terminal extension was observed in cysteine protease (Mottram et al. 1989 ), 3-mercaptopyruvate sulfurtransferase (Williams et al. 2003) and now in oligopeptidase B-2 (this work). In the cysteine proteases, the C-terminal extension displays 100 amino acids. Some functions were related to this C-terminal domain, however, the precise function of the C-terminal extension is unknown. It is not necessary for enzyme activity, but it is involved in Th2 polarization in Leishmania amazonensis (Alves et al. 2004 ). The C-terminal extension of 3-mercaptopyruvate sulfurtransferase displays 70 amino acids and plays a key role in facilitating the correct folding of the enzymes (Williams et al. 2003) .
The unusual C-terminal extension of oligopeptidase B-2 displayed 114 amino acids. This is the highest unusual C-terminal extension observed so far. Based on the fold of this protein family, it cannot be associated with enzyme activity (Polgar 2002) . When Leishmania and Trypanosoma oligopeptidases B-2 are compared, the C-terminal extension was more conserved than the β-propeller domain and less conserved than the catalytic domain (Table I) . No significant sequence homology was found when the C-terminal extension sequences of oligopeptidases B-2 were submitted to the BLAST program. No homology was seen with any of the oligopeptidases B deposited in the bank or any other proteins, it was present only in the oligopeptidases B-2 of Trypanosomatidae, indicating a new domain in the serine oligopeptidase.
Phylogenetic analysis
Based on the differential oligopeptidase B-2 sequences, we determined the phylogenetic classification of oligopeptidases B-2 of trypanosomatids. We conducted phylogenetic analysis of 42 sequences of the Prolyl-oligopeptidase family from different species using 9 prolyl oligopeptidases and 33 oligopeptidases-B. Sequence analysis was performed on amino acid sequences deduced from nucleotide sequences using sequences of catalytic domain. Phylogenetic analysis of sequences by neighbor-joining method (Fig. 3) showed the distinct clustering of prolyl oligopeptidase and oligopeptidase B. Oligopeptidase B is divided into two clades (clade I and clade II), supported strongly by the bootstrap test (Fig. 3) . Clade I contains classical oligopeptidases B and clade II contains oligopeptidases B-2. The phylogenetic analysis suggests that oligopeptidase B-2 is a new member of oligopeptidase B. In addition to trypanosomatid oligopeptidase B-2, two other eukaryotic oligopeptidases B are present in clade II. This result suggests a specific oligopeptidase B present in the eukaryotic cell. In clade I, eukaryotic oligopeptidases B are present in the same subclade, indicating a divergence between prokaryotic and eukaryotic oligopeptidases B. Therefore, oligopeptidase B-2 could be an useful phylogenetic markers for trypanosomatids. Fig. 3 . Phylogenetic analysis. Neighbor-joining phylogenetic analysis based on amino acid sequence of Prolyl-oligopeptidases of catalytic domain. The boot strap values are indicated above the branches. The oligopeptidase B-2 clade is shaded. The accession numbers of the taxa are also given Oligopeptidase B-2 from L. amazonensis with an unusual C-terminal extension dase B activity were observed during all life cycle stages of T. cruzi (Burleigh and Woolsey 2002) . As observed in T. cruzi, the results showed that the oligopetidase B-2 gene of L. amazonensis is expressed in both procyclic and metacyclic promastigotes and in axenic amastigotes suggesting that the gene is constitutively expressed throughout the life cycle of the parasite. The same results were observed with the oligopeptidase B gene of L. amazonensis (Guedes et al. 2007 ) and with ITS region used as control (not shown).
Conclusion
In the present study, we cloned and sequenced oligopeptidase B-2 from L. amazonensis. We are currently engaged in protein expression to biochemically and functionally characterize this enzyme, mainly in the S2 subsite determination and in the function of the unusual C-terminal extension.
